BlueWillow Biologics Information

BlueWillow Biologics is a privately-held biopharmaceutical company focused on developing and commercializing intranasal vaccines, based on its patented nanotechnology platform. Most infectious pathogens enter the body across mucosal surfaces. Yet few vaccines today provide mucosal immunity. BlueWillow’s vaccines are different. Our unique and patented adjuvant technology enables intranasal vaccines that elicit antibodies in the blood as well as across mucosal surfaces. These mucosal antibodies serve as “Bouncers at the Door” to keep infections out. Our studies point to increased protection against some of the world’s most severe respiratory and sexually transmitted diseases. BlueWillow’s lead product candidates include intranasal vaccines for RSV, influenza, pertussis, anthrax, HSV2 and chlamydia. The company's headquarters and laboratory facilities are located in Ann Arbor, Michigan.